Summary
June 2007, Vol. 8, No. 9, Pages 1283-1291 , DOI 10.1517/14656566.8.9.1283

Therapies for adrenal insufficiency

Kenji Oki1 & Kiminori Yamane2
1Graduate school student, Endocrinology and Metabolism. Hiroshima University, Department of Molecular and Internal Medicine, Graduate School of Biomedical Sciences, 1-2-3 Kasumi, Minami-ku, Hiroshima-City, Hiroshima 734-8551, Japan.
2Assistant professor, Endocrinology and Metabolism, Hiroshima University, Department of Molecular and Internal Medicine, Graduate School of Biomedical Sciences, Hiroshima, Japan
Author for correspondence



Adrenal insufficiency is a life-threatening disorder. In the treatment of adrenal insufficiency, it is essential to administer the optimal medication at the optimal dose. Glucocorticoids are the main therapeutic approach in all forms of adrenal insufficiency. The recommended protocol for maintenance therapy is 15 – 25 mg of hydrocortisone, divided into two or three separate doses. Patients with primary adrenal insufficiency generally receive mineralocorticoid replacement comprised of fludrocortisone 0.05 – 0.2 mg/day. Recently, dehydroepiandrosterone has been proposed as a new therapeutic approach, despite the lack of strong evidence for beneficial effects. Additional glucocorticoid supplementation should be administered in stressful states. During critical illness, inadequate or no temporary increase in the dose of the replacement glucocorticoid can lead to acute adrenal failure. When acute adrenal failure occurs, it becomes necessary to administer intravenous hydrocortisone.

Full Text | PDF (129 KB) | PDF Plus (254 KB)

Users who read this article also read:

Drug evaluation of clevidipine for acute hypertension
Ika Noviawaty, Guven Uzun, Adnan I Qureshi
Expert Opinion on Pharmacotherapy, Oct 2008, Vol. 9, No. 14, Pages 2519-2529.
Summary | Full Text | PDF (251 KB) | PDF Plus (222 KB) | Add to Favorites | Related 
Management of adrenal insufficiency in different clinical settings
Stefanie Hahner, Bruno Allolio
Expert Opinion on Pharmacotherapy, Nov 2005, Vol. 6, No. 14, Pages 2407-2417.
Summary | PDF (177 KB) | PDF Plus (306 KB) | Add to Favorites | Related 
 

Prev. Article | Next Article
View/Print PDF (129 KB)
View PDF Plus (254 KB)
Add to favourite
Email to a friend
TOC Alert | Citation Alert What is RSS?

 
 
Quick Search
for 
Authors:
Kenji Oki
Kiminori Yamane
Keywords:
Addison’s disease
adrenal crisis
adrenal insufficiency
dehydroepiandrosterone
glucocorticoid
mineralocorticoid